| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/18/2010 | WO2009134370A3 Methods and products relating to gsk3 beta regulation |
| 02/18/2010 | WO2009131702A3 Antibodies against fcrn and use thereof |
| 02/18/2010 | WO2009126898A3 Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus( (jev) and their use |
| 02/18/2010 | WO2009124281A9 Novel antibodies against cancer target block tumor growth, angiogenesis and metastasis |
| 02/18/2010 | WO2009120903A9 Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof |
| 02/18/2010 | WO2009079259A3 Antibodies against influenza virus and methods of use thereof |
| 02/18/2010 | WO2004099390A3 Molecules for disease detection and treatment |
| 02/18/2010 | US20100041874 High throughput methods for characterization of antibodies |
| 02/18/2010 | US20100041873 useful in therapeutic treatment of autoimmune and inflammatory diseases, particularly diseases mediated by T follicular helper cells, B cells TH cells or TH17 cells |
| 02/18/2010 | US20100041827 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly |
| 02/18/2010 | US20100041826 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly |
| 02/18/2010 | US20100041740 Flu vaccines and methods of use thereof |
| 02/18/2010 | US20100041612 Fragments of the Glucagon-Like Peptide-1 and Uses Thereof |
| 02/18/2010 | US20100041167 Drug for diagnosing large intestinal cancer and/or polyp, observing postoperative course and monitoring recurrence |
| 02/18/2010 | US20100041144 Mammalian Cytokine; Related Reagents |
| 02/18/2010 | US20100041136 Connective Tissue Growth Factor-2 |
| 02/18/2010 | US20100041102 Antagonists of pcsk9 |
| 02/18/2010 | US20100041078 Antibody-based gamma-hydroxybutyrate (ghb) detection method and device |
| 02/18/2010 | US20100041074 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 02/18/2010 | US20100041063 Anti-drug antibody assay |
| 02/18/2010 | US20100041060 Iron-regulating protein-2(irp-2) as a diagnostic for neurodegenerative disease |
| 02/18/2010 | US20100041032 Composition and methods for the detection of cripto-3 |
| 02/18/2010 | US20100041025 Compositons, methods and kits for real-time nucleic acid analysis in live cells |
| 02/18/2010 | US20100041012 Rationally designed antibodies |
| 02/18/2010 | US20100040675 Compositions and methods for promoting or inhibiting angiogenesis |
| 02/18/2010 | US20100040643 Flavivirus immunogens and methods of use |
| 02/18/2010 | US20100040640 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide |
| 02/18/2010 | US20100040636 Manipulation of Regulatory T Cell and Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists and Antagonists |
| 02/18/2010 | US20100040635 Neutralizing antibodies to influenza viruses |
| 02/18/2010 | US20100040634 Methods and compositions for modulating hgf/met |
| 02/18/2010 | US20100040629 Antibodies to c-Met |
| 02/18/2010 | US20100040627 Baff receptor (bcma), an immunoregulatory agent |
| 02/18/2010 | US20100040624 Human Tumor Necrosis Factor TR21 and Methods Based Thereon |
| 02/18/2010 | US20100040623 Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins |
| 02/18/2010 | US20100040621 Novel polpeptide and use thereof |
| 02/18/2010 | US20100040620 ANTI-CANCER ANTIBODIES AGAINST LEWISy AND LEWISb ANTIGENS |
| 02/18/2010 | US20100040618 Prevention of tumors with monoclonal antibodies against neu |
| 02/18/2010 | US20100040616 Treatment of autoimmune and inflammatory disease |
| 02/18/2010 | US20100040615 Digalactolipidic Antigen Exposed on the Surface of Apicomplex Parasites, and Diagnostic and Therapeutic Use Thereof |
| 02/18/2010 | US20100040613 Polypeptide constructs for sublingual administration |
| 02/18/2010 | US20100040610 Antagonists of pcsk9 |
| 02/18/2010 | US20100040606 Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
| 02/18/2010 | US20100040605 Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same |
| 02/18/2010 | US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 02/18/2010 | US20100040602 Antibodies against Human Cytimegalovirus (HCMV) |
| 02/18/2010 | US20100040601 Compositions and methods for treating herpes simplex virus infections and related diseases |
| 02/18/2010 | US20100040542 Chelator conjugates |
| 02/18/2010 | US20100040541 Structural Variants of Antibodies for Improved Therapeutic Characteristics |
| 02/18/2010 | US20100040540 Anti cd44 antibodies for eradicating leukaemic stem cells and breast cancer stem cells |
| 02/18/2010 | US20100040539 Vector System |
| 02/18/2010 | US20100040537 antibodies that are wild-type, chimeric, CDR grafted and humanized; disease or disorder in which prostaglandin E2 activity is detrimental, such as cancer, atuoimmune diseases, inflammatory diseases |
| 02/18/2010 | CA2734335A1 Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof |
| 02/18/2010 | CA2733782A1 Methods for purifying antibodies using protein a affinity chromatography |
| 02/18/2010 | CA2733742A1 Variant domain antibodies |
| 02/18/2010 | CA2733642A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | CA2732658A1 Methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted response |
| 02/17/2010 | EP2154536A1 Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes |
| 02/17/2010 | EP2154535A1 Protein scaffolds for antibody mimics and other binding proteins |
| 02/17/2010 | EP2154248A1 Compounds and methods for diagnosis of tuberculosis |
| 02/17/2010 | EP2154157A2 FC region variants |
| 02/17/2010 | EP2153848A2 Therapeutic monoclonal antibodies that neutralize botulinium neurotoxins |
| 02/17/2010 | EP2153845A1 Endoglin peptides, vaccines and methods for preparing the same |
| 02/17/2010 | EP2153843A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/17/2010 | EP2153840A1 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin |
| 02/17/2010 | EP2153234A2 Methods for early diagnosis of kidney disease |
| 02/17/2010 | EP2152872A2 Method for manufacturing a recombinant polyclonal protein |
| 02/17/2010 | EP2152861A2 Inducible mutagenesis of target genes |
| 02/17/2010 | EP2152858A2 Hematopoietic cells that express mosc-1 |
| 02/17/2010 | EP2152855A1 Recombinant protein production in avian ebx® cells |
| 02/17/2010 | EP2152755A1 Prevention and treatment of complement-associated eye conditions |
| 02/17/2010 | EP2152754A2 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 02/17/2010 | EP2152753A1 Antibodies against ramp3 |
| 02/17/2010 | EP2152751A1 Fusion or linked proteins with extended half life |
| 02/17/2010 | EP2152750A1 Anti-mdl-1 antibodies |
| 02/17/2010 | EP2152749A1 CRIg ANTAGONISTS |
| 02/17/2010 | EP2152748A1 Anti-notch1 nrr antibodies and methods using same |
| 02/17/2010 | EP2152747A2 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
| 02/17/2010 | EP2152746A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 02/17/2010 | EP2152745A1 Immunoglobulin purification |
| 02/17/2010 | EP2152744A1 Prion protein as a receptor for amyloid-beta oligomers |
| 02/17/2010 | EP2152740A1 Products for altering il-33 activity and methods therefor |
| 02/17/2010 | EP2152737A2 Methods of treating, diagnosing and detecting fgf21-associated disorders |
| 02/17/2010 | EP2152731A2 Klebsiella antigens |
| 02/17/2010 | EP2152318A2 Uses and compositions for treatment of psoriasis and crohn's disease |
| 02/17/2010 | EP2152309A1 Methods and device to neutralize soluble toxic agents in the brain |
| 02/17/2010 | EP2152308A1 New indications for anti- il-i-beta therapy |
| 02/17/2010 | EP2152307A1 Inhibition of tumor metastasis by anti neuropilin 2 antibodies |
| 02/17/2010 | EP2152300A1 Functional humanization of complementarity determining regions (cdrs) |
| 02/17/2010 | EP2152287A2 Methods for treating and preventing gi syndrome and graft versus host disease |
| 02/17/2010 | EP1578919B1 Endogenous retrovirus up-regulated in prostate cancer |
| 02/17/2010 | EP1443111B1 Desmin gene having novel point mutation causative of dilated cardiomyopathy |
| 02/17/2010 | EP1404816B1 Human hepatoma cell lines, methods for obtaining same and uses thereof |
| 02/17/2010 | EP1263954B1 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/17/2010 | EP1117783B1 Gene expressed in prostate cancer |
| 02/17/2010 | EP1071700B1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 02/17/2010 | CN101652389A Anti-ROBO4 antibodies and uses therefor |
| 02/17/2010 | CN101652388A Monoclonal human tumor-specific antibody |
| 02/17/2010 | CN101649351A Methods for diagnosis and therapy of cancer and composition useful therein |
| 02/17/2010 | CN101648998A Method for extracting human immune globulin from component I+III or component III |
| 02/17/2010 | CN101648997A IgY antibody for resisting botulinus toxin substrate peptide SubA as well as preparation method and application thereof |